Search
for
Sort by
Research 241–270 of 1000+
- Medications Most Commonly Associated With Erectile Dysfunction: Evaluation of the Food and Drug Administration National Pharmacovigilance Database
- Hair Regenerative Mechanisms of Red Ginseng Oil and Its Major Components in the Testosterone-Induced Delay of Anagen Entry in C57BL/6 Mice
- Chrysin Increases the Therapeutic Efficacy of Docetaxel and Mitigates Docetaxel-Induced Edema
- The mind-body problem; three equations and one solution represented by immaterial-material data
- Novel Strategies for Androgenetic Alopecia Therapy: Integrating Multifunctional Plant Extracts with Nanotechnology for Advanced Cutaneous Drug Delivery
- Erythrodermic Psoriasis in the Context of Emerging Triggers: Insights into Dupilumab-Associated and COVID-19-Induced Psoriatic Disease
- Emergency Wound Infection Monitoring and Treatment Based on Wearable Electrochemical Detection and Drug Release with Conductive Hydrogel
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- Sub-acute Toxicosis Caused by a Multiple Doses Tegafur/Uracil (UFT) for Suicide: A Case Report
- Chitosan Nanoparticle-Encapsulated Cordyceps militaris Grown on Germinated Rhynchosia nulubilis Reduces Type II Alveolar Epithelial Cell Apoptosis in PM2.5-Induced Lung Injury
- Alopecia Management Potential of Rosemary-Based Nanoemulgel Loaded with Metformin: Approach Combining Active Essential Oil and Repurposed Drug
- Herbal Treatment for Dermatologic Disorders
- Poster Abstracts
- Ingestion of a dietary supplement resulting in selenium toxicity
- Persistently curly hair phenotype with the use of nivolumab for squamous cell lung cancer
- Immunologic adverse reactions of β-blockers and the skin (Review)
- Prospective Case Series of Cutaneous Adverse Effects Associated With Dabrafenib and Trametinib
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- The Dermatological Spectrum of Coronavirus Disease-19 Disease: Cutaneous Signs for Diagnostics and Prognosis and an Expanded Classification
- Cutaneous Side Effects of Oral Contraceptives
- Safety Evaluation of Topical Valproate Application
- Cutaneous manifestations and considerations in COVID ‐19 pandemic: A systematic review
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- EGFR Inhibitors and Cutaneous Complications: A Practical Approach to Management
- Nanoparticles for Topical Application in the Treatment of Skin Dysfunctions—An Overview of Dermo-Cosmetic and Dermatological Products
- Cutaneous manifestations of COVID-19: a systematic review and analysis of individual patient-level data
- Adverse Reactions to Biologic Medications Used in Allergy and Immunology Diseases
- Dermatologic Adverse Events from Cancer Treatments
- Clinical Role of Oral Vitamin C and E Therapy in Skin and Hair Disorders
- Non-hemorrhage-related adverse effects of rivaroxaban